[1] 张玉霞,喻伦银,刘铭球,等.细胞周期调控研究进展.国外医学遗传学分册,2001,第24(5), 263
[2] Murillo G, Salti GI, Kosmeder JW, et al. Deguelin inhibits the growth of colon cancer cells through the induction of apoptosis and cell cycle arrest. Eur J Cancer. 2002;38(18): 2446-2454.
[3] Kim WY, Oh SH, Woo JK, et al.Targeting Heat Shock Protein 90 Overrides the Resistance of Lung Cancer Cells by Blocking Radiation-Induced Stabilization of Hypoxia-Inducible Factor-1 alpha. Cancer Res.2009;69(4):1624-1632.
[4] Lee JH, Lee DH, Lee HS, et al. Deguelin inhibits human hepatocellular carcinoma by antiangiogenesis and apoptosis. Oncology Reports.2008;20(1): 129-134.
[5] Gills JJ, Kosmeder J, Moon RC, et al. Effect of deguelin on UVB-induced skin carcinogenesis. J Chemother.2005;17(3): 297-301.
[6] Murillo G, Peng XJ, Torres K E O, et al. Deguelin Inhibits Growth of Breast Cancer Cells by Modulating the Expression of Key Members of the Wnt Signaling Pathway Cancer Prev Res (Phila). 2009;2(11):942-950.
[7] Westerfield M.The zebrafish Book-. Eugene: University of Oregon Press.1995:16-21.
[8] Kimmel CB, Ballard WW, Kimmel SR,et al. Stages of embryonic development of the zebrafish.Dev Dyn. 1995; 203(3):253-310.
[9] Cross L M, Cook MA, Lin S, et al. Rapid Analysis of Angiogenesis Drugs in a Live Fluorescent Zebrafish Assay. Arterioscler Thromb Vasc Biol.2003;23(5):911-912.
[10] Clurman BE, Roberts JM. Cell cycle and cancer. J Natl Cancer Inst.1995;87(20):1499-1501.
[11] Sakaguchi T, Watanabe A,Sawada H,et al. Prognostic value of cyclinE and p53 in expression in gastric carcinoma. Cancer. 1998;82:1238-1243.
[12] Lee HY, Suh YA, Kosmeder JW, et al.Deguelin-induced inhibition of cyclooxygenase-2expression in human bronchial epithelial cells. Clin Cancer Res. 2004;10:1074-1079.
[13] Dell'Eva R, Ambrosini C, Minghelli S, et al. The Akt inhibitor deguelin, is an angiopreventive agent also acting on the NF-kappaB pathway. Carcinogenesis.2007;28(2):404-413.
[14] Nair AS, Shishodia S, Ahn KS, et al. Deguelin, an Akt inhibitor, suppresses IkappaBalpha kinase activation leading to suppression of NF-kappaB-regulated gene expression, potentiation of apoptosis, and inhibition of cellular invasion.J Immunol.2006;77(8):5612-5622.
[15] Bortul R, Tazzari PL, Billi AM, et al. Deguelin,a PI3K/AKT inhibitor, enhances chemosensitivity of leukaemia cells with an active PI3K/AKT pathway.Br J Haematol.2005;129(5): 677-686.
[16] 刘红利,陈燕,崔国惠,等.鱼藤素对淋巴瘤Daudi 细胞株细胞增殖细胞凋亡的影响及其机制[J].中华肿瘤杂志,2007, 29(3): 176-180. |